Supplement
Limosilactobacillus reuteri MM4-1A clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Sahlgrenska University Hospital (2) · Innovacion y Desarrollo de Estrategias en Salud (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses limosilactobacillus reuteri MM4-1A is read from its arms, and is right about nine times in ten.
Testing it · 3
- L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in AdultsCompletedNot applicableInnovacion y Desarrollo de Estrategias en SaludNCT04037826Written as L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475
- Prevention of Early Postmenopausal Bone Loss With Lactobacillus ReuteriCompletedNot applicableSahlgrenska University HospitalNCT04169789Written as Lactobacillus reuteri ATCC PTA 6475 (L. reuteri 6475)
- Prevention of Glucocorticoid Induced Impairment of Bone MetabolismCompletedNot applicableSahlgrenska University HospitalNCT04767711Written as Lactobacillus reuteri ATCC PTA 6475 (L. reuteri 6475)